Advances in Antibody Preparation Techniques for Immunoassays of Total Aflatoxin in Food
MOLECULES
Authors: Wang, Yanan; Jiang, Jinqing; Fotina, Hanna; Zhang, Haitang; Chen, Junjie
Abstract
Aflatoxin (AF) contamination is a major concern in the food and feed industry because of its prevalence and toxicity. Improved aflatoxin detection methods are still needed. Immunoassays are an important method for total aflatoxin (TAF) analysis in food due to its technical advantages such as high specificity, sensitivity, and simplicity, but require high-quality antibodies. Here, we first review the three ways to prepare high-quality antibodies for TAF immunoassay, second, compare the advantages and disadvantages of antigen synthesis methods for B-group and G-group aflatoxins, and third, describe the status of novel genetic engineering antibodies. This review can provide new methods and ideas for the development of TAF immunoassays.
Modulation of antioxidant enzymes, SIRT1 and NF-kappa B by resveratrol and nicotinamide in alcohol-aflatoxin B1-induced hepatocellular carcinoma
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
Authors: Rawat, Divya; Chhonker, Saurabh Kumar; Naik, Rayees Ahmad; Koiri, Raj Kumar
Abstract
Hepatocellular carcinoma (HCC) is the fifth most commonly diagnosed cancer worldwide and is associated with poor prognosis. The current study aimed to assess the therapeutic efficacy of resveratrol when administered alone and in combination with nicotinamide against alcohol-aflatoxin B1-induced HCC. Results reveal that during the development and progression of cancer, there was a decline in the level of antioxidant enzymes catalase, glutathione peroxidase, glutathione reductase (GR), antioxidant glutathione, and glutathioneS-transferase, which is an enzyme of detoxification pathways. Treatment of resveratrol restored the level of catalase and glutathione peroxidase toward normal in alcohol-aflatoxin B1-induced HCC; however, nicotinamide worked in concert with resveratrol only in upregulating the activity of glutathione reductase, glutathione level, and glutathioneS-transferase. SIRT1 agonist resveratrol was observed to modulate the activity of antioxidant enzymes by negatively regulating the expression of nuclear factor-kappa B (NF-kappa B) in alcohol-aflatoxin B1-induced HCC, thereby suggesting a cross-talk between antioxidant enzymes SIRT1 and NF-kappa B during the development and progression of HCC and its therapeutics by resveratrol and nicotinamide.